3rd Quarter - Report
VERTEX PHARMACEUTICALS INCORPORATED for VERTEX PHARMACEUTICALS INCORPORATED
Income
—
Expenses
$370,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to raising awareness of Hepatitis C (no specific bills); H.R. 3293, H.R. 3288: FY 2010 Labor/HHS/Education Appropriations, provisions related to viral hepatitis funding; H.R. 3974: Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009, all provisions; FY 2011 Labor/HHS/Education Appropriations, provisions related to viral hepatitis funding; S. 3711: Viral Hepatitis and Liver Cancer Control and Prevention Act of 2010, all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEREMY ALLEN | — |
| AMIT K SACHDEV | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.